{
  "meta": {
    "title": "Pharmacology_Mini_Test_5_Chemotherapy",
    "url": "https://brainandscalpel.vercel.app/pharmacology-mini-test-5-chemotherapy-998428e1.html",
    "scrapedAt": "2025-11-30T07:33:18.420Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Anthracycline</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkylating agent</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Platinum compound</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58 year old woman has been diagnosed with locally advanced breast cancer and has been recommended for chemotherapy. She has history of myocardial infarction and congestive heart failure. Which anti-neoplastic drug should be best avoided in this patient?</span></p>",
      "unique_key": "Q238951",
      "question_audio": null,
      "question_video": null,
      "map_id": 238951,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Irreversible, dose-dependent cardiotoxicity, apparently a result of the generation of free radicals, is the most serious adverse reaction of anthracycline antibiotics.</em></strong></li><li><strong><em>Anthracyclines (doxorubicin, daunorubicin, idarubicin, etc.) are the anticancer drugs that have the highest risk of cardiac toxicity</em></strong><em>.</em></li><li><em>They <u>can cause a dose dependent dilated cardiomyopathy associated with a potentially fatal cardiac failure</u>.</em></li><li><em><u>This toxicity appears to result from increased production of free radicals within the myocardium</u></em><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/1E.jpg\"></li><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Irreversible, dose-dependent cardiotoxicity, apparently a result of the generation of free radicals, is the most serious adverse reaction of anthracycline antibiotics.</em></strong></li></ul></li></ul><p><strong>[Must Know]</strong></p><p><strong>[Anthracycline]</strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 926</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">It is nitrogen mustard</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolised by CYP3A4 to form active metabolite</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloracetaldehyde is active form</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Less neurotoxic then cyclophosphamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statement is least correct with respect to the use of ifosfamide as an anticancer agent?</span></p>",
      "unique_key": "Q238952",
      "question_audio": null,
      "question_video": null,
      "map_id": 238952,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><em>Ifosfamide has same toxicity profile as cyclophosphamide, however it has</em> <em>Higher risk of neurotoxicity and hemorrhagic cystitis</em><em>.</em></li><li><em>Ifosfamide is an oxazaphosphorine, similar to cyclophosphamide.</em></li><li><em>Alkylating agents have cytotoxic and radiomimetic (like ionizing radiation) actions.</em></li><li><em>Most agents are cell cycle non-specific, i.e. act on dividing as well as resting cells.</em></li><li><strong><em><u>Ifosfamide </u></em></strong><ul><li><em>This congener of cyclophosphamide has a longer and dose-dependent t&frac12;.</em></li><li><em><u>It has found utility in bronchogenic, breast, testicular, bladder, head and neck carcinomas, osteogenic sarcoma and some lymphomas.</u></em></li><li><strong><em>Ifosfamide produces greater neurotoxicity (mental changes, hallucinations, seizures, coma) and haemorrhagic cystis than other alkylating agents.</em></strong></li><li><em>To <strong>protect the bladder, MESNA</strong>, a &ndash;SH compound is mostly given with it.</em></li><li><em><u>Mesna is excreted in urine&mdash;binds and inactivates the vasicotoxic metabolites of ifosfamide and cyclophosphamide.</u></em></li><li><em><u>Ifosfamide causes less alopecia and is less emetogenic than cyclophosphamide.</u></em></li></ul></li><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Ifosfamide has same toxicity profile as cyclophosphamide, however it has </em></strong><strong><em>HIGHER risk of neurotoxicity and hemorrhagic cystitis</em></strong><strong><em>.</em></strong><strong><em>&nbsp;</em></strong></li></ul></li></ul><p><strong>Option A, B &amp; C: </strong><em>All other options given here are true for ifosfamide.</em></p><p><strong>[Good to Know]</strong></p><p><em><strong>[Ifosfamide]</strong></em></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 918</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Epirubicin</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Irinotecan</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old female patient presented to oncologist with painless breast lump. On examination and investigations, breast cancer was diagnosed. Echocardiography of the patient shows ejection fraction of just 25%. Which of the following drug should be avoided in this patient?</span></p>",
      "unique_key": "Q238953",
      "question_audio": null,
      "question_video": null,
      "map_id": 238953,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><em>Anthracycline antibiotics </em><em>act by inhibiting topoisomerase II.</em></li><li><em>Doxorubicin and daunorubicin are primarily used in acute leukemias whereas idarubicin and epirubicin display broader activity against solid tumors (breast carcinoma, Osteosarcoma, Ewing&rsquo;s sarcoma and soft tissue sarcoma).</em></li><li><strong><em>These agents also generate semiquinone free radicals that are responsible for cardiotoxicity (manifested in the form of dilated cardiomyopathy and congestive heart failure).</em></strong></li><li><strong><em>This adverse effect can be reduced by using &alpha;-tocopherol and dexrazoxane</em></strong><em> (a free radical scavenger). Liposomal forms of these drugs have decreased cardiac toxicity.</em></li><li><strong><em>Dilated cardiomyopathy is cumulative, dose-dependent and may present even after discontinuation of the anthracyclines.</em></strong></li><li><em>Earliest morphological feature is swelling of endoplasmic reticulum. It is followed by loss of cardiomyocytes (myofibrillar dropout).</em></li><li><em><u>Symptoms are similar to CHF including exertional dysponea, orthopnea and peripheral edema.</u></em></li><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Dilated cardiomyopathy is cumulative, dose-dependent and may present even after discontinuation of the anthracyclines.</em></strong></li></ul></li></ul><p><strong>[May Know]</strong></p><p><strong><em><strong>[Epirubicin]</strong></em></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 927</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Thromboembolism</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Bowel perforation</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Aplastic anemia</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Myelosuppression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42 year old premenopausal woman recently underwent partial mastectomy and radiation therapy for a small tumor in her breast. There were no lymph nodes involved and the tumor was estrogen-receptor positive. The oncologist explains that there is a little advantage to adding systemic chemotherapy in such an early-stage cancer but does recommend that the patient take tamoxifen. Which of the following is a concerning side effect of tamoxifen?</span></p>",
      "unique_key": "Q238954",
      "question_audio": null,
      "question_video": null,
      "map_id": 238954,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Patients with estrogen receptor-positive tumors benefit from tamoxifen adjunct treatment. It, however, carries a risk of thromboembolism as well as the potential to develop endometrial cancer.</em></strong><ul><li><em>Tamoxifen is a <u>SERM that acts as antagonist at estrogen receptors in the breast but agonist at blood vessels hence it can cause thromoembolism</u></em></li><li><strong><em>Similar to estrogen HRT, it increases the risk of deep vein thrombosis by 2&ndash;3 times.</em></strong></li></ul></li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/4E.jpg\"><p><strong>Option B</strong>: <em>Bevacizumab has been associated with the risk of bowel perforation.</em></p><p><strong>Option C &amp; D</strong>: <em>Many traditional chemotherapeutic agents are associated with myelosuppression, and in fact, that is the mechanism for the effects against leukemias.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Patients with estrogen receptor-positive tumors benefit from tamoxifen adjunct treatment. It, however, carries a risk of thromboembolism as well as the potential to develop endometrial cancer.</em></strong></li></ul></li></ul><p><strong>[Good to Know]</strong></p><p><strong><em><strong>[Tamoxifen]</strong></em></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 338</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhagic cystitis</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Acne</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral neuropathy</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiomyopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old woman brought to oncologist with metastatic breast cancer, is started on chemotherapy. Her initial treatment includes both cyclophosphamide and doxorubicin. For which of the following well-documented toxicity of doxorubicin's, caution is required?</span></p>",
      "unique_key": "Q238955",
      "question_audio": null,
      "question_video": null,
      "map_id": 238955,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Doxorubicin is associated with dose-limiting cardiomyopathy.</em></strong></li><li><em>Before using this agent, a thorough cardiac evaluation is required, including an echocardiogram or nuclear medicine scan of the heart.</em></li><li><strong><em>Anthracyclines (doxorubicin, daunorubicin, idarubicin, etc.) are the anticancer drugs that have the highest risk of cardiac toxicity</em></strong><em>.</em></li><li><em>They <u>can cause a dose dependent dilated cardiomyopathy associated with a potentially fatal cardiac failure</u>.</em></li><li><em><u>This toxicity appears to result from increased production of free radicals within the myocardium</u></em><em>.</em></li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/5E.jpg\"><p><strong>Option A</strong>: <em>Hemorrhagic cystitis is a complication of cyclophosphamide, prevented by co-administration of MESNA.</em></p><p><strong>Option B</strong>: <em>Acne is a side effect of prednisone and EGFR inhibitors.</em></p><p><strong>Option C</strong>: <em>Peripheral neuropathy is a result of taxanes such as paclitaxel.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Doxorubicin is associated with dose-limiting cardiomyopathy. Anthracyclines (doxorubicin, daunorubicin, idarubicin, etc.) are the anticancer drugs that have the highest risk of cardiac toxicity</em></strong><em>.</em></li></ul></li></ul><p><strong>[Good to Know]</strong></p><p><strong><strong>[Doxorubicin]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 926</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Leuprolide</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxyurea</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboplatin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 63 year old postmenopausal woman is diagnosed with early stage breast cancer, which is initially managed by partial mastectomy and radiation therapy. Her tumor was positive for expression of estrogen receptors. Which agent would you recommend to this patient to prevent relapse?</span></p>",
      "unique_key": "Q238956",
      "question_audio": null,
      "question_video": null,
      "map_id": 238956,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><em>Anastrozole is an aromatase inhibitor used to inhibit estrogen synthesis in the adrenal gland, a principle source in postmenopausal women.</em></li><li><em><u>Aromatase </u></em><em><u>is an enzyme responsible for the conversion of androstenedione</u></em> <em><u>(an androgen precursor) to estrone (estrogenic hormone).</u></em></li><li><strong><em>Drugs inhibiting</em></strong> <strong><em>aromatase include aminoglutethimide, anastrozole, exemestane and letrozole.</em></strong></li><li><strong><em>Aromatase</em></strong> <strong><em>inhibitors are useful in advanced breast carcinoma.</em></strong></li><li><strong><em>Anastrozole is useful as adjuvant therapy in early ER+ positive breast cancer as well as for palliation</em></strong><em> of advanced cases in postmenopausal women.</em></li><li><em>Risk of new tumor appearing in the contralateral breast was also lower with anastrozole.</em></li><li><strong><em>Many tamoxifen resistant cases responded with increased survival.</em></strong></li><li><em>Like letrozole, it is also a first line drug for early as well as advanced breast carcinoma in postmenopausal women.</em></li><li><em>Adverse effects include</em> <em>hot flushes, arthralgia and fatigue.</em></li></ul><p><strong>Option A</strong>: <em>Leuprolide and goserelin are GNRH antagonists used to treat prostate cancer.</em></p><p><strong>Option B</strong>: <em>Hydroxyurea is used in the treatment of some leukemias as well as myeloproliferative disorders.</em></p><p><strong>Option D</strong>: <em>Carboplatin is used in the treatment of ovarian cancers and others.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong></li><li><strong><em>Aromatase </em></strong><strong><em>is an enzyme responsible for the conversion of androstenedione</em></strong> <strong><em>(an androgen precursor) to estrone (estrogenic hormone).</em></strong></li><li><strong><em>Drugs inhibiting</em></strong> <strong><em>aromatase include aminoglutethimide, anastrozole, exemestane and letrozole. Aromatase</em></strong> <strong><em>inhibitors are useful in advanced breast carcinoma.</em></strong></li></ul><p><strong>[Good to Know]</strong></p><p><strong><em><strong>[Anastrozole]</strong></em></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 340</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Epoetin alfa</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Filgrastim</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferon alfa-2b</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Oprelvekin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54 year old woman is undergoing high-dose regimen with adriamycin and cyclophosphamide for breast cancer. As this treatment is particularly myelosuppressive, the oncologist is worried that her white blood cell count will drop dangerously low, making her susceptible to opportunistic infections. In addition to the chemotherapy, what is the oncologist likely to administer to prevent neutropenia?</span></p>",
      "unique_key": "Q238957",
      "question_audio": null,
      "question_video": null,
      "map_id": 238957,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Filgrastim is a recombinant form of granulocyte colony-stimulating factor (G-CSF) given to prevent chemotherapy-induced neutropenia.</em></strong></li><li><strong><em>Filgrastim is a recombinant G-CSF</em></strong><em> (Granulocyte- colony stimulating factor)</em></li><li><em><u>Pegylation of filgrastim help in increasing the duration of action of the drug.</u></em></li><li><em>These are </em><strong><em>used for leucopenia </em></strong><em>induced by cancer chemotherapy and are also useful </em><strong><em>for harvesting peripheral blood stem cells </em></strong><em>(these substances result in mobilization of stem cells from bone marrow to peripheral blood, which can be utilized for transplantation).</em></li><li><em>These drugs are administered by <strong>subcutaneous route</strong></em><strong><em>.</em></strong></li></ul><p><strong><em><u>Summary of different growth factors</u></em></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/7E.jpg\"><p><strong>Option A</strong>: <em>Epoetin alfa is commonly used to prevent anaemia while on chemotherapy.</em></p><p><strong>Option C</strong>: <em>Interferon alfa-2b is used in the management of specific leukemias and lymphomas.</em></p><p><strong>Option D</strong>: <em>Oprelvekin is an agent used to help treat chemotherapy-induced thrombocytopenia.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong></li><li><strong><em>Filgrastim is a recombinant form of granulocyte colony-stimulating factor (G-CSF) given to prevent chemotherapy-induced neutropenia.</em></strong></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[Filgrastim]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:936</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">MESNA</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Leucovorin</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Cilastatin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37 year old woman recently had a large soft tissue sarcoma surgically resected from her retroperitoneum. She is to receive both radiation and chemotherapy, with cyclophosphamide as part of her chemotherapy.Which of the following agent should be given in conjunction with this drug?</span></p>",
      "unique_key": "Q238958",
      "question_audio": null,
      "question_video": null,
      "map_id": 238958,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>MESNA is often given with cyclophosphamide and ifosfamide to help detoxify metabolic products that can cause hemorrhagic cystitis.</em></strong></li><li><em>To protect the bladder, MESNA, a &ndash;SH compound is mostly given with it.</em></li><li><strong><em>Mesna is excreted in urine&mdash;binds and inactivates the vasicotoxic metabolites of ifosfamide and cyclophosphamide.</em></strong></li></ul><p><strong><em><u>DRUGS USED FOR AMELIORATIVE CARE OF CANCER CHEMOTHERAPY</u></em></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/8E.jpg\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/8E1.jpg\"><p><strong>Option B</strong>: <em>Allopurinol is given with chemotherapy agents such as busulfan to reduce renal precipitation of urate.</em></p><p><strong>Option C</strong>: <em>Leucovorin is given to rescue patients in the case of methotrexate toxicity.</em></p><p><strong>Option D</strong>: <em>Cilastatin is an inhibitor of imipenem degradation.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong></li><li><strong><em>MESNA is often given with cyclophosphamide and ifosfamide to help detoxify metabolic products that can cause hemorrhagic cystitis.</em></strong></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[MESNA]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:919</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Erlotinib</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Gefitinib</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Cetuximab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 63-year-old woman develops metastatic colon cancer. The pathologist confirms that a biopsy specimen retrieved from a recent colonoscopy demonstrates that the tumor overexpresses epidermal growth factor receptor(EGFR). The oncologist decides to add a monoclonal antibody to EGFR to her treatment. Which of the following would be added?</span></p>",
      "unique_key": "Q238959",
      "question_audio": null,
      "question_video": null,
      "map_id": 238959,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em><u>Cetuximab </u></em></strong><ul><li><strong><em>This inhibitor of EGF receptor is a chimeric monoclonal antibody directed to the extracellular domain of the EGF receptor.</em></strong></li><li><em>Binding to the receptor, it prevents transmembrane signalling resulting in blockade of cell growth, proliferation and metastasis</em><em>.</em></li><li><strong><em>Cetuximab is approved for advanced/metastatic squamous carcinoma</em></strong> <strong><em>of head and neck in combination with radiation and/ or cisplatin based chemothrapy.</em></strong></li><li><em><u>EGF receptor positive metastatic colorectal cancer is another indication in which cetuximab is used either in combination with irinotecan + cisplatin or as monotherapy in resistant cases.</u></em></li></ul></li></ul><p><strong><em><u>Monoclonal antibodies against growth factor receptors</u></em></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/9E.jpg\"><ul><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Cetuximab</em></strong><strong><em> is monoclonal antibodies against Epidermal Growth Factor Receptor (EGFR). It is also called as Human Epidermal growth factor Receptor-1 (HER-1). It is approved for </em></strong><strong><em>colon cancer </em></strong><strong><em>[with irinotecan] and </em></strong><strong><em>head and neck cancer </em></strong><strong><em>[with radiation therapy].</em></strong></li></ul></li></ul><p><strong>[Good to Know]</strong></p><p><strong><strong>[Cetuximab]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 930</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Dimercaprol</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Ca Na2 EDTA</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">DMSA</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Ca Na2 EDTA & Dimercaprol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 11 year old child patient presented to paediatric ICU with abdominal pain, constipation, lethargy and altered mental status after accidental consumption of unknown material. On examination, there were blue lines on the gums. Investigations show serum lead levels were >80 mcg/dl. What is the most appropriate management of this patient?</span></p>",
      "unique_key": "Q238960",
      "question_audio": null,
      "question_video": null,
      "map_id": 238960,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em><u>Calcium disodium </u></em></strong><strong><em><u>EDTA</u></em></strong><strong><em><u>(Ca Na2 EDTA)</u></em></strong><ul><li><em>It is the calcium chelate of Na2 EDTA. Because this chelating agent has higher affinity for metals like Pb, Zn, Cd, Mn, Cu and some radioactive metals.</em></li><li><em>It can remove them from the body by exchanging with Ca held by it. Along with the toxic metal, some essential Zn may also be removed.</em></li></ul></li><li><strong><em><u>Uses</u></em></strong><ol><li><strong><em><u>Lead poisoning </u></em></strong><ol><li><em>This is the most important indication for CaNa2EDTA</em></li></ol></li><li><strong><em> It is also useful in Fe, Zn, Cu, Mn and radioactive metal</em></strong><em>, but not Hg poisoning, because Hg is more firmly bound to body constituents and is localized in areas not accessible to CaNa2 EDTA.</em></li></ol></li><li><strong><em><u>Dimercaprol</u></em></strong></li></ul><p>Also known as BAL(British Anti Lewsite), it is a <strong><u>parenterally</u></strong> administered heavy metal chelating agent that is used to treat arsenic, gold, copper and mercury poisoning.</p><p><strong><em><u>CHELATING AGENTS</u></em></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/10E.jpg\"><p><strong>Option A and B : </strong>Both Dimercaprol and EDTA-CaNa2 are to be used in acute cases.</p><p><strong>Option C </strong>: DMSA is an <strong><u>oral</u></strong> agent used to treat lead poisoning in non acute cases.</p><ul><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>It is the calcium chelate of Na2 EDTA. Because this chelating agent has higher affinity for metals like Pb, Zn, Cd, Mn, Cu and some radioactive metals.</em></strong></li></ul></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[Ca<sup>2+</sup> Na<sup>2+</sup> EDTA &amp; Dimercaprol]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:965</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Activated charcoal</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Mercury vapor</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Succimer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6 year old child is brought to the emergency room because he recently ingested numerous \"iron pills\" his mother was taking for her anemia. The child now has severe abdominal pain, bloody diarrhea, nausea and vomiting. His serum iron is dramatically elevated. What should be given to treat this toxicity?</span></p>",
      "unique_key": "Q238961",
      "question_audio": null,
      "question_video": null,
      "map_id": 238961,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Desferrioxamine is an iron chelator that is given systemically to bind iron and promote its excretion.</em></strong></li><li><strong><em><u>Desferrioxamine</u></em></strong><ul><li><em>Ferrioxamine is a long chain iron containing complex obtained from an actinomycete.</em></li><li><em>Chemical removal of iron from it yields desferrioxamine which has very high affinity for iron: <strong>1g is capable of chelating 85 mg of elemental iron.</strong></em></li><li><em>The straight chain desferrioxamine Molecule winds round ferric iron and <u>forms a stable nontoxic complex which is excreted in urine</u></em></li><li><strong><em>Desferrioxamine removes loosely bound iron as well as that from haemosiderin and ferritin</em></strong><em>, but not from haemoglobin or cytochrome.</em></li><li><em>Another desirable property is its <strong>low affinity for calcium</strong>.</em></li></ul></li><li><strong><em><u>Uses</u></em></strong><ul><li><em><u>Acute iron poisoning: mostly in children.</u></em></li><li><em><u>Transfusion siderosis: occurs in thalassemia </u></em><u>patients who receive repeated blood transfusion.</u></li></ul></li></ul><p><strong>Option A</strong>: <em>Activated charcoal, good for the absorption of numerous toxic</em> <em>ingestions, is ineffective in this case as it does not bind iron.</em></p><p><strong>Option B</strong>: <em>Mercury vapor is toxic and its ingestion is treated with dimercaprol or penicillamine.</em></p><p><strong>Option D</strong>: <em>Succimer is an orally available substance related to dimercaprol, and is used for treating lead toxicity.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Desferrioxamine is an iron chelator that is given systemically to bind iron and promote its excretion.</em></strong></li></ul></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[Desferrioxamine]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 966</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperbaric oxygen</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Fomepizole</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Lidocaine</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethylene glycol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old chronic alcoholic is brought to the emergency room with altered mental status and complains of visual loss. He reports ingesting wood alcohol (methanol). His laboratory test results demonstrate a severe anion gap and acute renal failure. Which of the following would be an appropriate therapy?</span></p>",
      "unique_key": "Q238962",
      "question_audio": null,
      "question_video": null,
      "map_id": 238962,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Fomepizole is an inhibitor of alcohol dehydrogenase, which might otherwise convert methanol to formic acid, which is the true toxin in such cases causing blindness and renal failure.</em></strong></li><li><strong><em><u>Methyl Alcohol (Methanol)</u></em></strong><ul><li><em>It is metabolized to formaldehyde (by alcohol dehydrogenase) and finally to formic acid (by aldehyde dehydrogenase).</em></li><li><em>Accumulation of </em><em>formic acid </em><em>may </em><em>result in lactic acidosis (high anion gap metabolic acidosis), blindness and death.</em></li><li><em>Specific toxicity of formic acid is retinal damage </em><em>leading to blindness.</em></li><li><em>Methanol poisoning can be treated by supportive measures, gastric lavage and sodium </em><em>bicarbonate </em><em>(to treat acidosis).</em></li><li><em>Ethanol </em><em>is useful because it </em><em>competitively inhibits the conversion of methanol to formic acid.</em></li><li><em>Fomepizole (4-Methylpyrazole) </em><em>can also be used in methanol poisoning&nbsp;</em><em>because it is a </em><em>specific inhibitor of alcohol dehydrogenase</em><em>.</em></li><li><em>Folic acid or folinic acid </em><em>can also be used because folate dependent systems are</em> <em>responsible for conversion of formic acid to CO2.</em></li></ul></li></ul><p><strong><em><u>TREATMENT OF POISONINGS</u></em></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizDec2024/PharmacoMiniV03122024/12E.jpg\"><p><strong>Option A</strong>: <em>Hyperbaric oxygen is used in the treatment of carbon monoxide poisoning.</em></p><p><strong>Option C</strong>: <em>Lidocaine can be used to help manage arrhythmias in the case of digoxin toxicity.</em></p><p><strong>Option D</strong>: <em>Ethylene glycol (antifreeze) can cause similar toxicity and is also&nbsp;</em><em>treated with fomepizole.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong></li><li><strong><em>Fomepizole is an inhibitor of alcohol dehydrogenase, which might otherwise convert methanol to formic acid, which is the true toxin in such cases causing blindness and renal failure.</em></strong></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[Fomepizole]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:423</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Flumazenil</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethyl alcohol</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Dextrose</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Strychnine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old man is brought to the emergency room by his friends because he \"passed out\". His friends tell the physician that they were at a party and the patient drank a couple of beers and took several Valium (diazepam). On examination the patient was unresponsive, with decreased respirations (8 per minute). What would be an appropriate treatment?</span></p>",
      "unique_key": "Q238963",
      "question_audio": null,
      "question_video": null,
      "map_id": 238963,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Flumazenil is a benzodiazepine antagonist used in the management</em></strong> <strong><em>of such overdoses.</em></strong></li><li><strong><em>Flumazenil </em></strong><strong><em>It is a BZD analogue which has little intrinsic activity (practically no effect on normal subjects), but competes with BZD agonists as well as inverse agonists for the BZD receptor and reverses their depressant or stimulant effects respectively.</em></strong></li><li><strong><em><u>Benzodiazepine Antagonist</u></em></strong><ul><li><strong><em>Flumazenil </em></strong><em>is the substance that acts as a competitive antagonist at BZD receptor.</em></li><li><em>It </em><em>blocks the depressant action of benzodiazepines, zolpidem and zaleplon as well as the convulsant action of inverse agonists (like </em><em>&beta; </em><em>carboline)</em><em>.</em></li><li><em>It is administered i.v. </em><strong><em>for </em></strong><em>the treatment of </em><strong><em>BZD poisoning </em></strong><em>(specific antidote) and can also be used to reverse BZD anaesthesia.</em></li><li><em>Its </em><strong><em>duration of action </em></strong><em>is </em><em>approximately 30-40 minutes </em><em>and </em><strong><em>half life </em></strong><em>is 1 </em><em>hour</em><em>.</em></li></ul></li><li><strong><em><u>Uses</u></em></strong><ol><li><strong><u> <em>To reverse BZD anaesthesia </em></u></strong><ul><li>Patients anaesthetized/sedated with a BZD wakeup, get oriented and regain motor control within 1 min of an i.v. injection of flumazenil</li></ul></li><li><strong><em><u> BZD overdose </u></em></strong><ul><li><em>Majority of patients of BZD overdose require only supportive measures like patent airway, maintenance of BP, cardiac and renal function (by fluid transfusion, etc.).</em></li><li><em>Practically all patients intoxicated with a BZD alone respond within 5 min (maximum total dose 1 mg).</em></li><li><em>Flumazenil blocks the hypnotic effect of zolpidem-like non-BZDs as well.</em></li></ul></li></ol></li></ul><p><strong>Option B</strong>: <em>Ethyl alcohol can be used to treat ingestion of both methanol and</em> <em>ethylene glycol; however, such use often results in ethanol intoxication, and fomepizole is preferred as it does not cause the same effects.</em></p><p><strong>Option C</strong>: <em>Dextrose is an effective treatment for altered mental status due to hypoglycemia in a diabetic patient.</em></p><p><strong>Option D</strong>: <em>Strychnine is a rat poison that can cause seizures when ingested, which are managed by giving diazepam.</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Flumazenil </em></strong><strong><em>It is a BZD analogue which has little intrinsic activity, but competes with BZD agonists as well as inverse agonists for the BZD receptor and reverses their depressant or stimulant effects respectively.</em></strong></li></ul></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[Flumazenil]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 435</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Naloxone</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Dimercaprol</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old known heroin addict is brought to the emergency room for unresponsiveness. On examination he is found to have pin-point pupils and respiratory depression. His fingerstick glucose measurement is normal. What is the most appropriate agent to administer at this point?</span></p>",
      "unique_key": "Q238964",
      "question_audio": null,
      "question_video": null,
      "map_id": 238964,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul> <li><strong><em>Given the patient's history and clinical findings, he is likely to be experiencing opioid overdose.</em></strong></li> <li><strong><em>The drug of choice in such a scenario is naloxone, an opioid</em></strong> <strong><em>receptor antagonist.</em></strong></li> <li><strong><em><u>Acute morphine poisoning </u></em></strong> <ul> <li><em>It may be accidental, suicidal or seen in drug abusers.</em></li> </ul> </li> <li><strong><em><u>Manifestations </u></em></strong> <ul> <li><strong><em>Stupor or coma, flaccidity, shallow and occasional breathing, cyanosis, pinpoint pupil, fall in BP</em></strong><em> and shock; convulsions may be seen in few, pulmonary edema occurs at terminal stages, death is due to respiratory failure.</em></li> </ul> </li> <li><strong><em><u>Treatment</u></em></strong> <ul> <li><em>It consists of <strong>respiratory support</strong> (positive pressure respiration also opposes pulmonary edema formation) and maintenance of BP (i.v.fluids, vasoconstrictors).</em></li> <li><strong><em>Gastric lavage</em></strong><em> should be done with potassium permanganate to remove unabsorbed drug.</em></li> <li><em>Lavage is indicated even when morphine has been injected.</em></li> </ul> </li> <li><strong><em><u>Specific antidote</u></em></strong> <ul> <li><strong><em>Naloxone</em></strong>4&ndash;0.8 mg i.v. repeated every 2&ndash;3 min till respiration picks up, is the <strong><em>specific antagonist of choice</em></strong> because it acts rapidly, does not have any agonistic action and does not <em>per se </em>depress respiration</li> </ul> </li> <li><strong><u>PURE OPIOID ANTAGONISTS</u></strong> <ul> <li><em>Three opioid antagonists are in use</em> <ul> <li><strong><em>Naloxone</em></strong></li> <li><strong><em>Naltrexone</em></strong></li> <li><strong><em>Nalmefene</em></strong></li> </ul> </li> </ul> </li> </ul> <p><strong>Option A</strong>: <em>Insulin is used to treat hyperglycemia, which is less likely to cause</em> <em>altered mental status than is hypoglycemia.</em></p> <p><strong>Option C</strong>: <em>Dimercaprol is a chelator used in many cases of heavy metal toxicity (i.e., lead).</em></p> <p><strong>Option D</strong>: <em>Penicillamine is used in the treatment of copper toxicity,&nbsp;</em><em>as in Wilson's disease.</em></p> <ul> <li><strong><em><u>Key takeaway</u></em></strong> <ul> <li><strong><em>The drug of choice in opioid overdose scenario is naloxone, an opioid receptor antagonist.</em></strong></li> </ul> </li> </ul> <p><strong>[ Know]</strong></p> <p><strong><strong>[Naloxone]</strong></strong></p> <p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 501-511</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Aminocaproic acid</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What should be given to correct coagulopathy due to an overdose of warfarin in a 73-year-old man?</span></p>",
      "unique_key": "Q238965",
      "question_audio": null,
      "question_video": null,
      "map_id": 238965,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Warfarin is an orally active inhibitor of vitamin K-dependent carboxylation of various clotting factors.</em></strong></li><li><strong><em><u>In the event of supra therapeutic doses of warfarin, the anticoagulation can be reversed by giving vitamin K.</u></em></strong></li><li><strong><em><u>Adverse effects of warfarin</u></em></strong><ul><li><strong><em>Bleeding as a result of extension of the desired pharmacological action is the most important problem causing ecchymosis, epistaxis, hematuria, bleeding in the g.i.t.</em></strong></li><li><em>Intracranial or other internal haemorrhages may even be fatal.</em></li><li><em>Bleeding is more likely if therapy is not properly monitored, or when the&nbsp;</em><em><u>International normalized ratio (INR) exceeds 4, or interacting drugs/contraindications are present.</u></em></li></ul></li><li><strong><em><u>Treatment</u></em></strong><ul><li><em><u>Withhold the anticoagulant.</u></em></li><li><strong><em>Give fresh blood transfusion; this supplies readymade clotting factors and replenishes lost blood. Alternatively fresh frozen plasma may be used as a source of clotting factors.</em></strong></li><li><strong><em>Give vit K1 which is the specific antidote</em></strong><em>, but it takes 6&ndash;24 hours for</em> <em>the clotting factors to be resynthesized and released in the blood after vit K administration.</em></li></ul></li></ul><p><strong>Option C</strong>: <em>Heparin is an intravenous preparation that is also an anticoagulation agent.</em></p><p><strong>Option A</strong>: <em>Aminocaproic acid inhibits plasminogen activation and is used in the treatment of hemophilia.</em></p><p><strong>Option D</strong>: <em>Vitamin D is used in cases of its deficiency or in the treatment of osteoporosis</em></p><ul><li><strong><em><u>Key takeaway</u></em></strong><ul><li><strong><em>Bleeding </em></strong><strong><em>is the most common </em></strong><strong><em>adverse effect </em></strong><strong><em>of all anticoagulants. </em></strong></li><li><strong><em>If a patient develops </em></strong><strong><em>bleeding due to overdose </em></strong><strong><em>of warfarin, </em></strong><strong><em>four factor concentrate or fresh frozen plasma </em></strong><strong><em>(to supply clotting factors) is the </em></strong><strong><em>treatment of choice </em></strong><strong><em>but </em></strong><strong><em>specific antidote is vitamin K1 </em></strong><strong><em>(but the action will be delayed).</em></strong></li></ul></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[Vitamin K]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 669</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}